Loading...
Loading...
Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc.. Spoken Alpha tracks KYMR's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks KYMR's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 80% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $1.08 | $0.95 | +14.2% | +8.4% | +7.0% |
| Q4 FY2026 | $1.08 | $0.95 | +14.1% | +8.4% | +8.0% |
| Q3 FY2026 | $0.97 | $0.88 | +10.0% | +6.5% | +5.3% |
| Q2 FY2026 | $1.06 | $0.96 | +10.7% | -1.3% | -1.9% |
| Q1 FY2025 | $1.14 | $0.99 | +14.8% | +3.1% | +0.3% |
| Q4 FY2025 | $0.96 | $0.84 | +14.7% | +5.9% | +7.7% |
| Q3 FY2025 | $1.00 | $0.91 | +10.2% | +9.5% | +7.5% |
| Q2 FY2025 | $0.96 | $0.87 | +10.3% | +8.4% | +5.7% |
| Q1 FY2024 | $0.99 | $0.95 | +3.7% | -1.1% | +0.8% |
| Q4 FY2024 | $0.95 | $0.91 | +4.6% | +3.2% | +5.0% |
Spoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
CEO since 2025 • 2/4 beats (50%) • guidance suspended Q3 FY2026
CFO since 2025 • 2/4 beats (50%) • guidance suspended Q1 FY2026
COO since 2026 • 1/2 beats (50%) • last guidance cut Q3 FY2026
OTHER_C_SUITE since 2026 • 1/2 beats (50%) • guidance suspended Q3 FY2026
OTHER_C_SUITE since 2025 • 2/4 beats (50%) • last call held guidance Q2 FY2026
OTHER_C_SUITE since 2025 • 2/4 beats (50%) • last guidance cut Q1 FY2026
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for KYMR.
curl https://api.spokenalpha.com/v1/companies/KYMR